Data as of Mar 11
| +0.47 / +1.88%|
The 3 analysts offering 12-month price forecasts for Bio-Reference Laboratories Inc have a median target of 33.00, with a high estimate of 36.00 and a low estimate of 28.00. The median estimate represents a +29.36% increase from the last price of 25.51.
The current consensus among 4 polled investment analysts is to Hold stock in Bio-Reference Laboratories Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.